FDAnews
www.fdanews.com/articles/209388-haemonetics-receives-ce-mark-for-vascade-vascular-closure-products

Haemonetics Receives CE Mark for Vascade Vascular Closure Products

September 14, 2022

Haemonetics received CE mark approval for its Vascade vascular closure and Vascade MVP venous vascular closure systems.

The Vascade system is designed for small-bore femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures, the company said.

The Vascade MVP system is intended for mid-bore multi-access femoral venous closure, generally used in electrophysiology procedures, which are tests performed to assess the heart's electrical system or activity. It is also used to diagnose abnormal heartbeats or arrhythmia.

With the CE mark in hand, the company said it believes its devices could raise the standard of care and meaningfully improve hospital operations.

View today's stories